1.
Preys CL, Zawatsky CLB, Massmann A, et al. Attitudes about pharmacogenomic testing vary by healthcare specialty. Pharmacogenomics. 2023. doi:10.2217/pgs-2023-0039.
1.
Hart R, Biesecker BB, Blout CL, et al. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med. 2019;21(5):1100-1110. doi:10.1038/s41436-018-0308-x.
1.
Weaver MD, Vetter C, Rajaratnam SMW, et al. Sleep disorders, depression and anxiety are associated with adverse safety outcomes in healthcare workers: A prospective cohort study. J Sleep Res. 2018;27(6):e12722. doi:10.1111/jsr.12722.
1.
Wolf SM, Amendola LM, Berg JS, et al. Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium. Genet Med. 2018;20(5):545-553. doi:10.1038/gim.2017.137.
1.
Song M, Zheng Y, Qi L, Hu FB, Chan AT, Giovannucci EL. Longitudinal Analysis of Genetic Susceptibility and BMI Throughout Adult Life. Diabetes. 2018;67(2):248-255. doi:10.2337/db17-1156.
1.
Mehta RS, Abu-Ali GS, Drew DA, et al. Stability of the human faecal microbiome in a cohort of adult men. Nat Microbiol. 2018;3(3):347-355. doi:10.1038/s41564-017-0096-0.
1.
Mukamal KJ, Jensen MK, Pers TH, Pai JK, Kraft P, Rimm EB. Multilocus heterozygosity and coronary heart disease: nested case-control studies in men and women. PLoS One. 2015;10(5):e0124847. doi:10.1371/journal.pone.0124847.